GPT Healthcare Limited carries a market capitalization of 12.98B, placing it among publicly traded companies globally. Its enterprise value stands at 9.86B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 12.98B |
| Enterprise Value | 9.86B |
GPT Healthcare Limited currently has 82.05M shares outstanding.
| Shares Outstanding | 82.05M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
GPT Healthcare Limited trades at a trailing price-to-earnings ratio of 22.33. The price-to-sales ratio is 2.00, and the price-to-book ratio stands at 11.49.
| PE Ratio | 22.33 |
| PS Ratio | 2.00 |
| PB Ratio | 11.49 |
| P/TBV Ratio | 3.51 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, GPT Healthcare Limited trades at an EV/EBITDA multiple of 17.27 and an EV/FCF ratio of 155.29. The EV/Sales ratio of 2.09 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 17.27 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.09 |
| EV / EBITDA | 17.27 |
| EV / EBIT | 17.27 |
| EV / FCF | 155.29 |
GPT Healthcare Limited maintains a current ratio of 1.12, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 33.84, indicating elevated leverage, while an interest coverage ratio of 6.93 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 1.12 |
| Quick Ratio | 0.61 |
| Debt / Equity | 33.84 |
| Debt / EBITDA | 1.60 |
| Interest Coverage | 6.93 |
GPT Healthcare Limited posts a return on equity of 33.39 and a return on invested capital of 13.73.
| Return on Equity (ROE) | 33.39 |
| Return on Assets (ROA) | 9.95 |
| Return on Invested Capital (ROIC) | 13.73 |
| Return on Capital Employed (ROCE) | 25.61 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 17.93 |
Over the trailing twelve months, GPT Healthcare Limited has paid 125.85M in income taxes, reflecting an effective tax rate of 22.96.
| Income Tax | 125.85M |
| Effective Tax Rate | 22.96 |
GPT Healthcare Limited's stock has declined approximately -0.59086052% over the past 52 weeks. The 50-day moving average sits at 144.67, while the 200-day moving average is 138.32.
| Beta (5Y) | N/A |
| 52-Week Price Change | -0.59086052% |
| 50-Day Moving Average | 144.67 |
| 200-Day Moving Average | 138.32 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, GPT Healthcare Limited generated 4.73B in revenue and converted that into 422.21M in net income, yielding earnings per share of 5.15. EBITDA reached 570.95M, while operating income came in at 570.95M.
| Revenue | 4.73B |
| Gross Profit | 2.98B |
| Operating Income | 570.95M |
| Pretax Income | 548.06M |
| Net Income | 422.21M |
| EBITDA | 570.95M |
| EBIT | 570.95M |
| Earnings Per Share (EPS) | 5.15 |
GPT Healthcare Limited holds 481.96M in cash and equivalents against 911.80M in total debt, resulting in a net debt position of 119.77M. Total book value stands at 820.55M, with working capital of 97.85M providing operational flexibility.
| Cash & Cash Equivalents | 481.96M |
| Total Debt | 911.80M |
| Net Debt | 119.77M |
| Equity (Book Value) | 820.55M |
| Book Value Per Share | 10.01 |
| Working Capital | 97.85M |
GPT Healthcare Limited operates with a gross margin of 63.15, reflecting its pricing power and cost economics. The operating margin of 12.08 and net profit margin of 8.93 provide insight into operational efficiency.
| Gross Margin | 63.15 |
| Operating Margin | 12.08 |
| Pretax Margin | 11.60 |
| Profit Margin | 8.93 |
| EBITDA Margin | 12.08 |
GPT Healthcare Limited posts an Altman Z-Score of 4.35, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.35 |